Refining Immunotherapy Approvals

被引：8

作者：

Bates, Susan E. ^{[1
]}

机构：

[1] Columbia Univ, Med Ctr, New York, NY 10027 USA

来源：

CLINICAL CANCER RESEARCH | 2017年 / 23卷 / 17期

关键词：

CLINICAL-TRIALS;

D O I：

10.1158/1078-0432.CCR-17-2025

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

收藏

页码：4948 / 4949

页数：2

相关论文

共 4 条

[1]

Advancing Clinical Trials to Streamline Drug Development [J].

Bates, Susan E. ;

Berry, Donald A. ;

Balasubramaniam, Sanjeeve ;

Bailey, Stuart ;

LoRusso, Patricia M. ;

Rubin, Eric H. .

CLINICAL CANCER RESEARCH, 2015, 21 (20) :4527-4535

[2]

Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1 [J].

Champiat, Stephane ;

Dercle, Laurent ;

Ammari, Samy ;

Massard, Christophe ;

Hollebecque, Antoine ;

Postel-Vinay, Sophie ;

Chaput, Nathalie ;

Eggermont, Alexander ;

Marabelle, Aurelien ;

Soria, Jean-Charles ;

Ferte, Charles .

CLINICAL CANCER RESEARCH, 2017, 23 (08) :1920-1928

[3]

Characterization of outcomes in patients with metastatic non-small cell lung cancer treated with programmed cell death protein 1 inhibitors past RECIST version 1.1-defined disease progression in clinical trials [J].

Kazandjian, Dickran ;

Keegan, Patricia ;

Suzman, Daniel L. ;

Pazdur, Richard ;

Blumenthal, Gideon M. .

SEMINARS IN ONCOLOGY, 2017, 44 (01) :3-7

[4]

The B7 family and cancer therapy: Costimulation and coinhibition [J].

Zang, Xingxing ;

Allison, James P. .

CLINICAL CANCER RESEARCH, 2007, 13 (18) :5271-5279